Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
A new study by the EIT has researched the presence of female entrepreneurs in deep tech start-ups across the European Union. Since 2010 it has doubled in numbers but the figure remains low compared to other entrepreneurial sectors. The report also highlights that receiving seed funding remains a big challenge for these aspiring businesswomen. All details about the study can be found here
2024-11-26
|
15 hours ago |
Webinars for SMEs |
2024-11-05
|
3 weeks ago |
NCP Flanders team: Reshuffle of responsibilities of our NCP Advisors - Horizon Europe... |
2024-10-25
|
1 month ago |
EIT Manufacturing: Innovate Together 2024 Call is open |
2024-10-21
|
1 month ago |
Temporary suspension of the EIC Accelerator short proposals submissions |
2024-10-08
|
1 month ago |
EIT Higher Education Institutions Initiatve: Open Call for Proposals 2024 on Innovati... |
2024-10-07
|
1 month ago |
EIT Health Flagships 2025 - Call on Digital Transformation of Healthcare |
2024-09-23
|
2 months ago |
Number of submitted proposals EIC-transition-open |
2024-09-13
|
2 months ago |
EIC Pathfinder successful applications from March 2024: €138 million to support bold... |
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Deployment: Best use of technologies
The European Commission (DG CONNECT) has launched the following procurement procedure: Better Internet for Kids (BIK) Platform – EU Coordination (EC-CNECT/LUX/2024/OP/0097) The EU-funded Better Internet for Kids portal (at https://better-internet-for-kids.europa.eu) and the associated coordination tasks are the main subject of th... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.